Profile data is unavailable for this security.
About the company
BCAL Diagnostics Limited is an Australia-based screening and diagnostic company focused on early diagnosis of breast cancer. The Company’s core activity is the development of a novel blood screening test to improve the early diagnosis and monitoring of breast cancer, which is available to all women. It is developing diagnostic technology to assist in the early detection of breast cancer by identifying, measuring and validating specific biomarkers enriched in the patient’s blood. It is engaged in the research and development of non-invasive diagnostic technologies designed to complement existing imaging technologies, such as the mammogram. Its BCAL laboratory employs liquid chromatography mass spectrometry (LCMS) platforms to build on the Company's clinical research and leverage progress. The Company’s BCAL test is a lipid biomarker blood (Breast Cancer Associated Lipids test) test with the potential to be used for breast cancer prevention, screening, and monitoring.
- Revenue in AUD (TTM)3.05m
- Net income in AUD-6.40m
- Incorporated2010
- Employees--
- LocationBCAL Diagnostics LtdSuite 506, Level 5, 50 Clarence StreetSYDNEY 2000AustraliaAUS
- Websitehttps://www.bcaldiagnostics.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ImExHS Ltd | 24.68m | -3.42m | 19.05m | 400.00 | -- | 1.26 | -- | 0.7718 | -0.0794 | -0.0794 | 0.5713 | 0.3314 | 1.10 | 97.11 | 3.78 | 61,692.52 | -15.28 | -22.17 | -20.83 | -29.21 | 31.95 | 29.75 | -13.85 | -31.20 | 1.53 | -4.58 | 0.0593 | -- | 14.79 | 26.48 | -37.97 | -- | 5.61 | -- |
Lumos Diagnostics Holdings Ltd | 17.25m | -13.32m | 23.86m | -- | -- | 1.49 | -- | 1.38 | -0.0276 | -0.0276 | 0.035 | 0.0215 | 0.426 | 4.37 | 7.02 | -- | -32.88 | -40.29 | -54.62 | -58.07 | 63.77 | 49.44 | -77.19 | -151.15 | 0.6949 | -6.01 | 0.5314 | -- | 5.66 | 19.53 | 4.22 | -- | -47.99 | -- |
Cleanspace Holdings Ltd | 15.72m | -3.13m | 28.74m | -- | -- | 1.50 | -- | 1.83 | -0.0405 | -0.0405 | 0.2036 | 0.2469 | 0.5714 | 1.49 | 4.45 | -- | -11.37 | -3.31 | -13.04 | -4.14 | 72.25 | 74.42 | -19.89 | -4.38 | 3.92 | -- | 0.1528 | -- | 30.01 | 7.29 | 61.54 | -- | -20.61 | -- |
Nova Eye Medical Ltd | 23.45m | -8.79m | 35.50m | 130.00 | -- | 1.66 | -- | 1.51 | -0.0436 | -0.0436 | 0.1149 | 0.0932 | 0.7785 | 0.7744 | 7.44 | -- | -29.18 | -15.92 | -36.41 | -18.97 | 86.64 | 83.45 | -37.49 | -57.51 | 1.84 | -19.35 | 0.1357 | -- | 36.90 | 7.54 | 42.52 | -- | -18.46 | -- |
Universal Biosensors, Inc. | 7.08m | -12.39m | 35.77m | 97.00 | -- | 1.71 | -- | 5.05 | -0.0498 | -0.0498 | 0.0285 | 0.0701 | 0.2301 | 0.6592 | 4.25 | -- | -40.27 | -21.79 | -48.77 | -27.14 | 56.95 | 46.16 | -175.04 | -209.31 | 3.75 | -- | 0.0023 | -- | 46.58 | -37.48 | 74.90 | -- | 26.83 | -- |
BCAL Diagnostics Ltd | 3.05m | -6.40m | 37.66m | -- | -- | 3.84 | -- | 12.36 | -0.0257 | -0.0257 | 0.0124 | 0.0273 | 0.2953 | -- | 1.03 | -- | -62.03 | -56.30 | -81.11 | -67.80 | -- | -- | -210.07 | -235.31 | -- | -128.30 | 0.1507 | -- | 9.18 | 64.04 | -26.44 | -- | 173.87 | -- |
Curvebeam AI Ltd | 6.53m | -23.10m | 38.11m | 50.00 | -- | 1.01 | -- | 5.84 | -0.0774 | -0.0774 | 0.0222 | 0.1184 | 0.1047 | 0.3624 | 2.17 | -- | -37.05 | -- | -59.32 | -- | 46.08 | -- | -353.94 | -- | 1.54 | -14.28 | 0.2905 | -- | -18.97 | -- | 55.62 | -- | -- | -- |
Cardiex Ltd | 11.18m | -6.77m | 39.71m | 26.00 | -- | 9.72 | -- | 3.55 | -0.0251 | -0.0251 | 0.0501 | 0.0139 | 0.8222 | 0.3786 | 8.61 | -- | -49.77 | -74.03 | -313.68 | -158.85 | 92.86 | 85.82 | -60.53 | -152.33 | 0.9687 | -2.22 | 0.4859 | -- | 129.87 | 22.44 | 64.18 | -- | -13.83 | -- |
Micro-X Ltd | 15.22m | -9.77m | 40.13m | -- | -- | 2.81 | -- | 2.64 | -0.0187 | -0.0187 | 0.0289 | 0.0245 | 0.5323 | 0.9086 | 5.03 | -- | -34.15 | -39.41 | -48.53 | -50.99 | 62.05 | 64.09 | -64.15 | -108.20 | 1.68 | -38.35 | 0.2186 | -- | 1.45 | 23.43 | 9.20 | -- | -26.39 | -- |
Compumedics Limited | 49.72m | -338.00k | 53.29m | 155.00 | -- | 2.82 | 43.26 | 1.07 | -0.0017 | -0.0017 | 0.3125 | 0.1028 | 1.22 | 1.98 | 3.81 | 320,767.80 | -0.829 | -5.06 | -1.73 | -8.70 | 52.43 | 51.90 | -0.6798 | -4.95 | 0.6131 | -0.2934 | 0.3202 | -- | 17.24 | 3.68 | 94.48 | -- | -6.97 | -- |